Renal disposition of colistin in the isolated perfused rat kidney

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 7, 2009, Pages 2857-2864

  Ma, Zheng ^a   Wang, Jiping ^a   Nation, Roger L ^b   Li, Jian ^b   Turnidge, John D ^c   Coulthard, Kingsley ^c   Milne, Robert W ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; COLISTIN A; COLISTIN B; GLYCYLGLYCINE; HYDROCHLORIC ACID; ORGANIC CATION TRANSPORTER; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISPOSITION; DRUG STRUCTURE; GLOMERULUS FILTRATION RATE; GRAM NEGATIVE BACTERIUM; ISOLATED KIDNEY; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; URINE PH;

ANIMALS; ANTI-BACTERIAL AGENTS; COLISTIN; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67649984938     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00030-09     Document Type: Article

References (33)

1. Barnett, M., S. R. Bushby, and S. Wilkinson. 1964. Sodium sulphomethyl derivatives of polymyxins. Br. J. Pharmacol. Chemother. 23:552-574.
2. Bekersky, I. 1983. The isolated perfused kidney as a pharmacological tool. Trends Pharmacol. Sci. 4:6-7.
3. Bergen, P. J., J. Li, C. R. Rayner, and R. L. Nation. 2006. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1953-1958.
4. Buyse, M., F. Berlioz, S. Guilmeau, A. Tsocas, T. Voisin, G. Peranzi, D. Merlin, M. Laburthe, M. J. Lewin, C. Roze, and A. Bado. 2001. PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J. Clin. Investig. 108:1483-1494.
5. Craig, W. A., and C. M. Kunin. 1973. Dynamics of binding and release of the polymyxin antibiotics by tissues. J. Pharmacol. Exp. Ther. 184:757-765.
6. Evans, M. E., D. J. Feola, and R. P. Rapp. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967.
7. Falagas, M. E., and S. K. Kasiakou. 2006. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit. Care 10:R27.
8. Koepsell, H., and H. Endou. 2004. The SLC22 drug transporter family. Pflugers Arch. 447:666-676.
9. Koepsell, H., V. Gorboulev, and P. Arndt. 1999. Molecular pharmacology of organic cation transporters in kidney. J. Membr. Biol. 167:103-117.
10. Kunin, C. M. 1970. Binding of antibiotics to tissue homogenates. J. Infect. Dis. 121:55-64.
11. Kunin, C. M., and A. Bugg. 1971. Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J. Infect. Dis. 124:394-400.
12. Lee, W., and R. B. Kim. 2004. Transporters and renal drug elimination. Annu. Rev. Pharmacol. Toxicol. 44:137-166.
13. Lepsy, C. S., R. J. Guttendorf, A. R. Kugler, and D. E. Smith. 2003. Effects of organic anion, organic cation, and dipeptide transport inhibitors on cefdinir in the isolated perfused rat kidney. Antimicrob. Agents Chemother. 47:689-696.
14. Li, J., W. Milne Robert, L. Nation Roger, D. Turnidge John, C. Smeaton Timothy, and K. Coulthard. 2003. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrobial Agents Chemother. 47:1766-1770.
15. Li, J., R. L. Nation, J. D. Turnidge, R. W. Milne, K. Coulthard, C. R. Rayner, and D. L. Paterson. 2006. Colistin: the re-emerging antibiotic for multidrugresistant gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
16. Li, J., L. Nation Roger, W. Milne Robert, D. Turnidge John, and K. Coulthard. 2005. Evaluation of colistin as an agent against multi-resistant gram-negative bacteria. Int. J. Antimicrob. Agents 25:11-25.
17. Livermore, D. M. 2004. The need for new antibiotics. Clin. Microbiol. Infect. 10(Suppl. 4):1-9.
18. Ma, Z., J. Wang, J. P. Gerber, and R. W. Milne. 2008. Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed Life Sci. 862:205-212.
19. Ocheltree, S. M., H. Shen, Y. Hu, R. F. Keep, and D. E. Smith. 2005. Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J. Pharmacol. Exp. Ther. 315:240-247.
20. Pritchard, J. B., and D. S. Miller. 1993. Mechanisms mediating renal secretion of organic anions and cations. Physiol. Rev. 73:765-796.
21. Rennick, B., and A. Farah. 1956. Studies on the renal tubular transport of tetraethylammonium ion in the dog. J. Pharmacol. Exp. Ther. 116:287-295.
22. Rennick, B. R., G. K. Moe, R. H. Lyons, S. W. Hoobler, and R. Neligh. 1947. Absorption and renal excretion of the tetraethylammonium ion. J. Pharmacol. Exp. Ther. 91:201-207.
23. Shen, H., D. E. Smith, T. Yang, Y. G. Huang, J. B. Schnermann, and F. C. Brosius III. 1999. Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am. J. Physiol. 276:F658-F665.
24. Shitara, Y., H. Sato, and Y. Sugiyama. 2005. Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu. Rev. Pharmacol. Toxicol. 45:689-723.
25. Slitt, A. L., N. J. Cherrington, D. P. Hartley, T. M. Leazer, and C. D. Klaassen. 2002. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab. Dispos. 30:212-219.
26. Talbot, G. H., J. Bradley, J. E. Edwards, Jr., D. Gilbert, M. Scheld, and J. G. Bartlett. 2006. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42:657-668.
27. Tamai, I., H. Yabuuchi, J. Nezu, Y. Sai, A. Oku, M. Shimane, and A. Tsuji. 1997. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 419:107-111.
28. Terada, T., K. Sawada, M. Irie, H. Saito, Y. Hashimoto, and K. Inui. 2000. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2. Pflugers Arch. 440:679-684.
29. van Montfoort, J. E., B. Hagenbuch, G. M. Groothuis, H. Koepsell, P. J. Meier, and D. K. Meijer. 2003. Drug uptake systems in liver and kidney. Curr. Drug Metab. 4:185-211.
30. Wang, J., R. L. Nation, A. M. Evans, and S. Cox. 2004. Isolated rat kidney perfused with dextran and bovine serum albumin: a stable model for investigating renal drug handling. J. Pharmacol. Toxicol. Methods 49:105-113.
31. Wu, X., R. L. George, W. Huang, H. Wang, S. J. Conway, F. H. Leibach, and V. Ganapathy. 2000. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim. Biophys. Acta 1466:315-327.
32. Yabuuchi, H., I. Tamai, J. Nezu, K. Sakamoto, A. Oku, M. Shimane, Y. Sai, and A. Tsuji. 1999. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J. Pharmacol. Exp. Ther. 289:768-773.
33. Ziv, G., J. F. Nouws, and C. A. van Ginneken. 1982. The pharmacokinetics and tissue levels of polymyxin B, colistin, and gentamicin in calves. J. Vet. Pharmacol. Ther. 5:45-58.